One aspect of the invention relates to AI-helper compositions comprising an AI compound (e.g., melatonin) and one or more helper esters. The AI-helper compositions disclosed herein can be used for effective transdermal delivery of the AI compound to a subject. Another aspect of the invention relates to applications and preparations of the AI-helper compositions.
